These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1732426)

  • 1. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
    Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
    J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
    Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
    Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
    Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
    Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of carboplatin in children with progressive low-grade gliomas.
    Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
    J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.
    Castleberry RP; Cantor AB; Green AA; Joshi V; Berkow RL; Buchanan GR; Leventhal B; Mahoney DH; Smith EI; Hayes FA
    J Clin Oncol; 1994 Aug; 12(8):1616-20. PubMed ID: 8040674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
    Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
    Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of carboplatin or iproplatin in cervical cancer.
    Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
    Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin and recurrent childhood brain tumors.
    Allen JC; Walker R; Luks E; Jennings M; Barfoot S; Tan C
    J Clin Oncol; 1987 Mar; 5(3):459-63. PubMed ID: 3546620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.
    de Wit R; Tesselaar M; Kok TC; Seynaeve C; Rodenburg CJ; Verweij J; Helle PA; Stoter G
    Eur J Cancer; 1991; 27(11):1383-5. PubMed ID: 1835851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
    van Glabbeke M; Renard J; Pinedo HM; Cavalli F; Vermorken J; Sessa C; Abele R; Clavel M; Monfardini S
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):255-62. PubMed ID: 3281842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
    Mahoney DH; Cohen ME; Friedman HS; Kepner JL; Gemer L; Langston JW; James HE; Duffner PK; Kun LE
    Neuro Oncol; 2000 Oct; 2(4):213-20. PubMed ID: 11265230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer.
    Trask C; Silverstone A; Ash CM; Earl H; Irwin C; Bakker A; Tobias JS; Souhami RL
    J Clin Oncol; 1991 Jul; 9(7):1131-7. PubMed ID: 2045855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study.
    Alberts D; Mason N; Surwit E; Weiner S; Hammond N; Deppe G
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():83-92. PubMed ID: 3910225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group.
    Warren K; Jakacki R; Widemann B; Aikin A; Libucha M; Packer R; Vezina G; Reaman G; Shaw D; Krailo M; Osborne C; Cehelsky J; Caldwell D; Stanwood J; Steinberg SM; Balis FM
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):343-7. PubMed ID: 16408203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
    Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
    Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group).
    Nitschke R; Pratt C; Harris M; Krischer J; Vietti TJ; Grier H; Kamps W; Toledano S
    Invest New Drugs; 1992 Jul; 10(2):93-6. PubMed ID: 1323551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report.
    Gaynon PS; Ettinger LJ; Moel D; Siegel SE; Baum ES; Krivit W; Hammond GD
    Cancer Treat Rep; 1987 Nov; 71(11):1039-42. PubMed ID: 3315195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
    Fouladi M; Nicholson HS; Zhou T; Laningham F; Helton KJ; Holmes E; Cohen K; Speights RA; Wright J; Pollack IF;
    Cancer; 2007 Dec; 110(11):2535-41. PubMed ID: 17932894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.